Anti-Microbial Effects of Vaccinium Macrocarpon (Cranberry) Extract on Serotypes 26 and 45 of Escherichia Coli as a Prophylaxis of Recurrent Urinary Tract Infection (UTI) Cranberry Extract Against E. coli Serotypes

Main Article Content

Dr. Zahid Zia
Humaira Farooqi
Safia Firdous
Salman Kazmi
Daniah Rizwan
Azka Aiman


Background: Urinary tract infection (UTI) is the second most common type of bacterial infection globally, affecting people of different age groups. Cranberry is renowned for its antibacterial properties and has been used to treat UTIs in recent years.

Objective: This study aimed to assess the antimicrobial effects of cranberry extract on the prophylaxis of recurrent UTI caused by different serotypes of Escherichia coli (E. coli).

Methods: This quasi-experimental study recruited 60 recurrent UTI patients from the Urology department of King Edward Medical University, Lahore, Pakistan. Patients with a history of recurrent UTIs caused by E. coli were included. Urine microscopy and culture tests were performed, and only E. coli-positive cases were serotyped. Patients received Vaccinium macrocarpon (cranberry) extract at a dose of 500 mg/day for four weeks along with their standard treatment. Follow-up evaluations were conducted after one and three months to assess UTI symptoms and the presence of E. coli in urine samples. Statistical analysis was performed using SPSS version 25, with quantitative variables expressed as mean ± standard deviation and qualitative variables as frequencies and percentages.

Results: Of the 60 patients, 15 (25%) were positive for E. coli. Serotyping revealed 8 patients (53%) with serotype 26 and 7 patients (47%) with serotype 45. After three months of treatment, cranberry extract eradicated E. coli in 12 patients (80%); specifically, it eradicated 100% of serotype 45 and 62% of serotype 26 cases.

Conclusion: Cranberry extract (500 mg/day) for three months demonstrated significant antimicrobial effects on E. coli serotypes 26 and 45, with greater efficacy observed in serotype 45. These findings suggest cranberry extract as a potential prophylactic treatment for recurrent UTIs.

Keywords: Cranberry extract, recurrent UTI, E. coli serotypes, antimicrobial effects, prophylactic treatment, Vaccinium macrocarpon, urinary tract infection, Escherichia coli

Article Details

How to Cite
Zia, Z., Farooqi, H., Firdous, S., Kazmi, S., Rizwan, D., & Aiman, A. (2024). Anti-Microbial Effects of Vaccinium Macrocarpon (Cranberry) Extract on Serotypes 26 and 45 of Escherichia Coli as a Prophylaxis of Recurrent Urinary Tract Infection (UTI): Cranberry Extract Against E. coli Serotypes. Journal of Health and Rehabilitation Research, 4(2), 1649–1653.
Author Biographies

Dr. Zahid Zia, Pathology Department

Dr Zahid Zia is working as a pathologist at Pathology Department, King Edward Medical University, Lahore, Pakistan. He specialized in family medicine (MCPS) in 2014 and completed Mphil in Microbiology in 2021. He is also working as family physician and surgeon since last decade.

Humaira Farooqi, Pathology Department, King Edward Medical University, Lahore, Pakistan.

Dr Humaira farooqi is currently working as a post graduate trainee in the Pathology department of King Edward Medical University, Lahore, Pakistan.

Salman Kazmi, South Medical Ward, Mayo Hospital, Lahore, Pakistan.

Senior Registrar South Medical Ward, Mayo Hospital, Lahore, Pakistan.

Daniah Rizwan, Pathology Department, King Edward Medical University, Lahore, Pakistan.

Dr. Daniah Rizwan is working as medical officer at medical unit of Mayo Hospital, Lahore. She has done MBBS from king Edward medical university, Lahore, Pakistan.

Azka Aiman, 2. Faculty of Rehabilitation and Allied Health Sciences, Riphah International University, Lahore, Pakistan.

Azka Aiman completed Masters in Microbiology from University of the Punjab, Lahore, Pakistan. She is currently working as lecturer at Riphah International University, Lahore, Pakistan.


Foxman, B., Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infectious Disease Clinics, 2014. 28(1): p. 1-13.

Sivick, K.E. and H.L. Mobley, Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infection and immunity, 2010. 78(2): p. 568-585.

Celik, O., et al., Current medical diagnosis and management of vesicoureteral reflux in children. Nephro-Urology Monthly, 2014. 6(1).

Yoshimura, N. and M.B. Chancellor, Neurophysiology of lower urinary tract function and dysfunction. Reviews in urology, 2003. 5(Suppl 8): p. S3.

Barber, A.E. and M.A. Mulvey, Clinical Infectious Diseases Advance Access published November 11, 2013.

Baron, E.J., et al., A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM) a. Clinical infectious diseases, 2013. 57(4): p. e22-e121.

Blumenthal, M., G. Ferrier, and C. Cavaliere, Total sales of herbal supplements in United States show steady growth. HerbalGram, 2006.

Szajdek, A. and E.J. Borowska, Bioactive Compounds and Health-Promoting Properties of Berry Fruits: A Review. Plant Foods for Human Nutrition, 2008. 63(4): p. 147-156.

Ruel, G., et al., Favourable impact of low-calorie cranberry juice consumption on plasma HDL-cholesterol concentrations in men. British Journal of Nutrition, 2006. 96(2): p. 357-364.

Pappas, E. and K. Schaich, Phytochemicals of cranberries and cranberry products: characterization, potential health effects, and processing stability. Critical reviews in food science and nutrition, 2009. 49(9): p. 741-781.

Bodet, C., et al., Potential oral health benefits of cranberry. Critical Reviews in Food Science and Nutrition, 2008. 48(7): p. 672-680.

Howell, A.B., et al., A-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity. Phytochemistry, 2005. 66(18): p. 2281-2291.

Wang, C.-H., et al., Cranberry-containing products for prevention of urinary tract infections in susceptible populations: a systematic review and meta-analysis of randomized controlled trials. Archives of internal medicine, 2012. 172(13): p. 988-996.

Luís, Â., F. Domingues, and L. Pereira, Can cranberries contribute to reduce the incidence of urinary tract infections? A systematic review with meta-analysis and trial sequential analysis of clinical trials. The Journal of urology, 2017. 198(3): p. 614-621.

Jepson, R.G., G. Williams, and J.C. Craig, Cranberries for preventing urinary tract infections. Cochrane database of systematic reviews, 2012(10).

Vicariotto, F., Effectiveness of an association of a cranberry dry extract, D-mannose, and the two microorganisms Lactobacillus plantarum LP01 and Lactobacillus paracasei LPC09 in women affected by cystitis: a pilot study. Journal of clinical gastroenterology, 2014. 48: p. S96-S101.

Feliciano, R.P., et al., Ratio of “A-type” to “B-type” proanthocyanidin interflavan bonds affects extra-intestinal pathogenic Escherichia coli invasion of gut epithelial cells. Journal of agricultural and food chemistry, 2014. 62(18): p. 3919-3925.

Hidalgo, G., M. Chan, and N. Tufenkji, Inhibition of Escherichia coli CFT073 fliC expression and motility by cranberry materials. Applied and environmental microbiology, 2011. 77(19): p. 6852-6857.

Hidalgo, G., et al., Induction of a state of iron limitation in uropathogenic Escherichia coli CFT073 by cranberry-derived proanthocyanidins as revealed by microarray analysis. Applied and Environmental Microbiology, 2011. 77(4): p. 1532-1535.

Howell, A.B., et al., Inhibition of the adherence of P-fimbriated Escherichia coli to uroepithelial-cell surfaces by proanthocyanidin extracts from cranberries. New England Journal of Medicine, 1998. 339(15): p. 1085-1086.

Ranfaing, J., et al., Propolis potentiates the effect of cranberry (Vaccinium macrocarpon) against the virulence of uropathogenic Escherichia coli. Scientific reports, 2018. 8(1): p. 1-11.

Most read articles by the same author(s)